Sensus Healthcare Reports Third Quarter 2023 Financial Results
BOCA RATON, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2023.
- Revenues for the third quarter of 2023 were $3.9 million, compared with $9.0 million for the third quarter of 2022.
- Cost of sales was $1.9 million for the third quarter of 2023, compared with $3.1 million for the prior-year quarter.
- Selling and marketing expense was $1.3 million for the third quarter of 2023, compared with $1.8 million for the prior-year quarter.
- General and administrative expense was $1.5 million for the third quarter of 2023, compared with $1.2 million for the third quarter of 2022.